本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

19.44
-0.0900-0.46%
盘后19.440.00000.00%17:50 EDT
成交量:155.80万
成交额:3,019.87万
市值:24.43亿
市盈率:-10.82
高:19.55
开:19.38
低:18.98
收:19.53
数据加载中...
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities